Possible role of DPP4 inhibitors to promote hippocampal neurogenesis in Alzheimer’s disease

References

• Mezey É, Chandross KJ, Harta G, et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000;290:1779–1782.
   PubMed Web of Science ®Google Scholar
• Sigurjonsson OE, Perreault M-C, Egeland T, et al. Adult human hematopoietic stem cells produce neurons efficiently in the regenerating chicken embryo spinal cord. Proc Natl Acad Sci USA. 2005;102:5227–5232.
   PubMed Web of Science ®Google Scholar
• Shyu W-C, Lin S-Z, Chiang M-F, et al. Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing β1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci. 2006;26:3444–3453.
   PubMed Web of Science ®Google Scholar
• Okano H, Sakaguchi M, Ohki K, et al. Regeneration of the central nervous system using endogenous repair mechanisms. J Neurochem. 2007;102:1459–1465.
   PubMed Web of Science ®Google Scholar
• Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2mnull mice. Leukemia. 2002;16:1992–2003.
   PubMed Web of Science ®Google Scholar
• Burwinkel M, Riemer C, Schwarz A, et al. Role of cytokines and chemokines in prion infections of the central nervous system. Int J Dev Neurosci. 2004;22:497–505.
   PubMed Web of Science ®Google Scholar
• González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5:69–81.
   PubMed Web of Science ®Google Scholar
• Zhong J, Rajagopalan S. Dipeptidyl peptidase-4 regulation of SDF-1/CXCR4 axis: implications for cardiovascular disease. Front Immunol. 2015;6:477.
   PubMed Web of Science ®Google Scholar
• Horuk R. Chemokine receptors. Cytokine Growth Factor Rev. 2001;12:313–335.
   PubMed Web of Science ®Google Scholar
• Barkho BZ, Zhao X. Adult neural stem cells: response to stroke injury and potential for therapeutic applications. CSCR. 2011;6:327–338.
   Google Scholar
• Imitola J, Raddassi K, Park KI, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci. 2004;101:18117–18122.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Murakami F. Chemokine CXCL12 and its receptors in the developing central nervous system: emerging themes and future perspectives. Dev Neurobiol. 2012;72:1349–1362.
   PubMed Web of Science ®Google Scholar
• Vaquero J, Zurita M. Functional recovery after severe CNS trauma: current perspectives for cell therapy with bone marrow stromal cells. Prog Neurobiol. 2011;93:341–349.
   PubMed Web of Science ®Google Scholar
• Creutzfeldt W. The incretin concept today. Diabetologia. 1979;16:75–85.
   PubMed Web of Science ®Google Scholar
• Holst JJ. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology. 1994;107:1848–1855.
   PubMed Web of Science ®Google Scholar
• Holst JJ, Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol-Endocrinol Metabol. 2004;287:E199–E206.
   PubMed Web of Science ®Google Scholar
• Hölscher C. Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. J Endocrinol. 2014;221:T31–T41.
   PubMed Web of Science ®Google Scholar
• Athauda D, Foltynie T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action. Drug Discov Today. 2016;21:802–818.
   PubMed Web of Science ®Google Scholar
• Durinx C, Lambeir AM, Bosmans E, et al. Molecular characterization of dipeptidyl peptidase activity in serum. Eur J Biochem. 2000;267:5608–5613.
   PubMedGoogle Scholar
• Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565–568.
   PubMed Web of Science ®Google Scholar
• Lambeir A-M, Proost P, Durinx C, et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem. 2001;276:29839–29845.
   PubMed Web of Science ®Google Scholar
• McQuibban GA, Butler GS, Gong J-H, et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 2001;276:43503–43508.
   PubMed Web of Science ®Google Scholar
• Röhrborn D, Wronkowitz N, Eckel J. DPP4 in diabetes. Front Immunol. 2015;6:386.
   PubMed Web of Science ®Google Scholar
• Kosaraju J, Gali CC, Khatwal RB, et al. Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer’s disease. Neuropharmacology. 2013;72:291–300.
   PubMed Web of Science ®Google Scholar
• Kosaraju J, Murthy V, Khatwal RB, et al. Vildagliptin: an anti‐diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin‐induced Alzheimer’s disease. J Pharm Pharmacol. 2013;65:1773–1784.
   PubMed Web of Science ®Google Scholar
• Kosaraju J, Madhunapantula SV, Chinni S, et al. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer’s disease. Behav Brain Res. 2014;267:55–65.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Zigova T, et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res. 2003;12:255–270.
   PubMedGoogle Scholar
• Nikolic WV, Hou H, Town T, et al. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular β-amyloid deposits in Alzheimer mice. Stem Cells Dev. 2008;17:423–440.
   PubMed Web of Science ®Google Scholar
• Bachstetter AD, Pabon MM, Cole MJ, et al. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci. 2008;9:1.
   PubMed Web of Science ®Google Scholar
• Shen Q, Goderie SK, Jin L, et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science. 2004;304:1338–1340.
   PubMed Web of Science ®Google Scholar
• Kalinkovich A, Spiegel A, Shivtiel S, et al. Blood-forming stem cells are nervous: direct and indirect regulation of immature human CD34+ cells by the nervous system. Brain Behav Immun. 2009;23:1059–1065.
   PubMed Web of Science ®Google Scholar
• Kuci S, Kuci Z, Schmid S, et al. Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells. Cell Prolif. 2008;41:12–27.
   PubMed Web of Science ®Google Scholar
• Taguchi A, Soma T, Tanaka H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model. J Clin Invest. 2004;114:330–338.
   PubMed Web of Science ®Google Scholar
• Guo Y, Shi D, Li W, et al. Proliferation and neurogenesis of neural stem cells enhanced by cerebral microvascular endothelial cells. Microsurgery. 2008;28:54–60.
   PubMed Web of Science ®Google Scholar
• Liu J, Solway K, Messing RO, et al. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci. 1998;18:7768–7778.
   PubMed Web of Science ®Google Scholar
• Curtis MA, Penney EB, Pearson AG, et al. Increased cell proliferation and neurogenesis in the adult human Huntington’s disease brain. Proc Natl Acad Sci. 2003;100:9023–9027.
   PubMed Web of Science ®Google Scholar
• Jin K, Peel AL, Mao XO, et al. Increased hippocampal neurogenesis in Alzheimer’s disease. Proc Natl Acad Sci. 2004;101:343–347.
   PubMed Web of Science ®Google Scholar
• Kohler RE, Comerford I, Townley S, et al. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol. 2008;18:504–516.
   PubMed Web of Science ®Google Scholar
• Duda DG, Kozin SV, Kirkpatrick ND, et al. CXCL12 (SDF1α)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res. 2011;17:2074–2080.
   PubMed Web of Science ®Google Scholar
• Khan MZ, Brandimarti R, Shimizu S, et al. The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ. 2008;15:1663–1672.
   PubMed Web of Science ®Google Scholar
• Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3:687–694.
   PubMed Web of Science ®Google Scholar
• Bezzi P, Domercq M, Brambilla L, et al. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity. Nat Neurosci. 2001;4:702–710.
   PubMed Web of Science ®Google Scholar
• Wang Q, Xu Y, Chen J-C, et al. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer’s disease mouse model. Brain Res. 2012;1459:15–26.
   PubMed Web of Science ®Google Scholar
• O’leary H, Ou X, Broxmeyer HE. The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation. Curr Opin Hematol. 2013;20:314.
   PubMed Web of Science ®Google Scholar
• Huber BC, Brunner S, Segeth A, et al. Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4+ stem cells into the ischaemic heart. Cardiovasc Res. 2011;90:529–537.
   PubMed Web of Science ®Google Scholar
• Jungraithmayr W, De Meester I, Matheeussen V, et al. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardio-Thor Surg. 2011;41:1166–1173.
   PubMed Web of Science ®Google Scholar
• Togel FE, Westenfelder C. Role of SDF-1 as a regulatory chemokine in renal regeneration after acute kidney injury. Kidney Int Suppl. 2011;1:87–89.
   Web of Science ®Google Scholar
• Wan X, Xia W, Gendoo Y, et al. Upregulation of stromal cell-derived factor 1 (SDF-1) is associated with macrophage infiltration in renal ischemia-reperfusion injury. PLoS One. 2014;9:e114564.
   PubMed Web of Science ®Google Scholar
• Stumm RK, Rummel J, Junker V, et al. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci. 2002;22:5865–5878.
   PubMed Web of Science ®Google Scholar
• Ratajczak M, Kucia M, Reca R, et al. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow. Leukemia. 2004;18:29–40.
   PubMed Web of Science ®Google Scholar
• Hatch HM, Zheng D, Jorgensen ML, et al. SDF-1α/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Clon Stem Cells. 2002;4:339–351.
   PubMedGoogle Scholar
• Kollet O, Shivtiel S, Chen Y-Q, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest. 2003;112:160–169.
   PubMed Web of Science ®Google Scholar
• Sweeney EA, Lortat-Jacob H, Priestley GV, et al. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood. 2002;99:44–51.
   PubMed Web of Science ®Google Scholar
• Ratajczak M, Zuba-Surma E, Kucia M, et al. The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20:1915–1924.
   PubMed Web of Science ®Google Scholar
• Tchernychev B, Ren Y, Sachdev P, et al. Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells. Proc Natl Acad Sci. 2010;107:22255–22259.
   PubMed Web of Science ®Google Scholar
• Lefrançois M, Lefebvre M-R, Saint-Onge G, et al. Agonists for the chemokine receptor CXCR4. ACS Med Chem Lett. 2011;2:597–602.
   PubMed Web of Science ®Google Scholar
• During MJ, Cao L, Zuzga DS, et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med. 2003;9:1173–1179.
   PubMed Web of Science ®Google Scholar
• Hamilton A, Hölscher C. Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system. Neuroreport. 2009;20:1161–1166.
   PubMed Web of Science ®Google Scholar
• Sun M-K, Alkon DL. The “memory kinases”: roles of PKC isoforms in signal processing and memory formation. Prog Mol Biol Transl Sci. 2014;122:31–59.
   PubMed Web of Science ®Google Scholar
• Farag SS, Srivastava S, Messina-Graham S, et al. In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells Dev. 2012;22:1007–1015.
   Web of Science ®Google Scholar
• Gault VA, Hölscher C. GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur J Pharmacol. 2008;587:112–117.
   PubMed Web of Science ®Google Scholar
• Gengler S, McClean PL, McCurtin R, et al. Val (8) GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice. Neurobiol Aging. 2012;33:265–276.
   PubMed Web of Science ®Google Scholar
• Wang M-D, Huang Y, Zhang G-P, et al. Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway. Neuroscience. 2012;226:388–396.
   PubMed Web of Science ®Google Scholar
• Iwai T, Ito S, Tanimitsu K, et al. Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes. Neurosci Res. 2006;55:352–360.
   PubMed Web of Science ®Google Scholar
• Hamilton A, Patterson S, Porter D, et al. Novel GLP‐1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J Neurosci Res. 2011;89:481–489.
   PubMed Web of Science ®Google Scholar
• Hunter K, Hölscher C. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci. 2012;13:1.
   PubMed Web of Science ®Google Scholar
• Abbas T, Faivre E, Hölscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer’s disease. Behav Brain Res. 2009;205:265–271.
   PubMed Web of Science ®Google Scholar
• McClean PL, Parthsarathy V, Faivre E, et al. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s disease. J Neurosci. 2011;31:6587–6594.
   PubMed Web of Science ®Google Scholar
• Parthsarathy V, Hölscher C. Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model. PLoS One. 2013;8:e58784.
   PubMed Web of Science ®Google Scholar
• Perry T, Lahiri DK, Sambamurti K, et al. Glucagon‐like peptide‐1 decreases endogenous amyloid‐β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron. J Neurosci Res. 2003;72:603–612.
   PubMed Web of Science ®Google Scholar
• D’amico M, Di Filippo C, Marfella R, et al. Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer’s prone mice. Exp Gerontol. 2010;45:202–207.
   PubMed Web of Science ®Google Scholar
• Isik AT, Soysal P, Yay A, et al. The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer’s disease. Diabetes Res Clin Pract. 2017;123:192–198.
   PubMed Web of Science ®Google Scholar